First Page | Document Content | |
---|---|---|
Date: 2016-05-25 01:37:50Clinical medicine Medicine Antineoplastic drugs Breakthrough therapy Pharmacology Bristol-Myers Squibb Monoclonal antibodies Immune system Programmed cell death protein 1 Nivolumab Pharmac Pembrolizumab | 24 MayDanae Staples-Moon Therapeutic Group Manager PHARMAC PO BoxAdd to Reading ListSource URL: www.nzma.org.nzDownload Document from Source WebsiteFile Size: 204,92 KBShare Document on Facebook |